For US PatientsHealthcare Provider Website Medical InformationPrescribing Information
Patient InformationImportant Safety Information
Patient InformationImportant Safety InformationFor US Patients
AKEEGA®—the only FDA-approved treatment option combining two drugs into one tablet for adults with BRCA+ metastatic castration-resistant prostate cancer (mCRPC)
Living with advanced prostate cancer can be challenging; ask your doctor how AKEEGA ®, a once-daily treatment option, may help.
Not an actual patient
Johnson & Johnson has built a legacy of innovation in the treatment of prostate cancer with the goal of extending life and helping patients enjoy the highest possible quality of life.